EFPIA HCP/HCO and R&D Reporting

Interactions between pharmaceutical companies and healthcare professionals (HCPs) and healthcare organizations (HCOs) have a profound and positive influence on the quality of patient treatments and value of future research.

To ensure that the interactions meet the high integrity standards that patients, governments and other stakeholders expect, the European Federation of Pharmaceutical Industries and Associations (EFPIA) and its member associations and companies have adopted codes and guidelines.

The EFPIA Disclosure Code was created to foster greater transparency and build greater trust between the pharmaceutical industry, the medical community and wider society.

As an EFPIA-member Merck KGaA, Darmstadt, Germany, is fully committed to the efforts of strengthening these relationships and to protect their integrity. Therefore the company documents and discloses all Transfers of Value to Healthcare Professionals, and Healthcare Organizations as well as Transfers of Value arising out of Research and Development (R&D) activities in every EFPIA country where Merck KGaA, Darmstadt, Germany, operates.

Disclosure is made on an annual basis and the reporting period covers a full calendar year. First reporting period is the year 2015.

Merck KGaA, Darmstadt, Germany, certifies that it has made its best efforts to comply with the EFPIA Disclosure Code in full, in line with applicable national laws and regulations. For further information please see the Self-Certification Letter, signed by the Chairman of the Executive Board and CEO.

Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating / has relationships with, following the objectives and provisions included in the applicable codes. Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed off to.

These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.

For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.

To view our Disclosure Reports please click here

• View reports